ARIAD Pharmaceuticals , Inc. ( ARIA ) June 11, 2013 5:40 pm ET Executives Harvey J. Berger ..... http://seekingalpha.com/article/1495622- ariad - pharmaceuticals -inc-presents-at-goldman-sachs-34th-annual-global-healthcare-conference-jun-11-2013-02-40-pm …
Ariad Pharmaceuticals ( ARIA +0.6% ) will test the effectiveness of Iclusig on metastatic and/or unresectable gastrointestinal stromal tumors in a Phase …
… While trying to explain exactly why the cancer medicine Iclusig (ponatinib) is a real breakthrough for Ariad Pharmaceuticals ( ARIA ) I realized that I needed to provide a bit of background first. Some will find the quick biology lesson …
ARIAD Pharmaceuticals , Inc. ( ARIA ) June 03, 2013 8:30 am ET Executives Maria E. Cantor ..... http://seekingalpha.com/article/1477351- ariad - pharmaceuticals -inc-shareholder-analyst-call?source=feed …
ARIAD Pharmaceuticals , Inc. ( ARIA ) 38th Annual Deutsche Bank ..... time it is. Next, we have ARIAD Pharmaceuticals . My name is Robyn Karnauskas ..... com/article/1470981- ariad - pharmaceuticals -ceo-presents-at-38th-annual-deutsche-bank-health-care-conference-transcript …
By C.R. Jackson: Ariad Pharmaceuticals Ariad Pharmaceuticals ( ARIA ) is a Cambridge, Massachusetts-based biotechnology company focused on small-molecule drugs that target proteins and pathways involved in cancer . On December 14, 2012 …
ARIAD Pharmaceuticals , Inc. ( ARIA ) May 20, 2013 8:30 am ET Executives Harvey J. Berger ..... http://seekingalpha.com/article/1447691- ariad - pharmaceuticals -inc-presents-at-ubs-global-healthcare-conference-may-20-2013-08-30-am …
ARIAD Pharmaceuticals , Inc. ( ARIA ) Bank of America Merrill Lynch ..... Dr. Harvey Berger, CEO of ARIAD Pharmaceuticals and hope to have plenty of Q ..... com/article/1435441- ariad - pharmaceuticals -ceo-presents-at-bank-of-america-merrill-lynch-health-care-conference-transcript …
Ariad Pharmaceuticals ( ARIA ) Q1 2013 Earnings Call May 07, 2013 8:30 am ET Executives ..... href='http://seekingalpha.com/article/1410071- ariad - pharmaceuticals -management-discusses-q1-2013-results-earnings-call-transcript …
More on Ariad Pharmaceuticals ' ( ARIA ) Q1 report : The fiery debate surrounding Q1 Iclusig sales ( estimates were $3.5-6M) is over as ARIA says net sales of the leukemia drug were $6.4M during the period …